Volume 19 No 6 (2021)
 Download PDF
Evaluation of Fractalkine and Migration Inhibitory in the Patient with Atherosclerosis
Huda W.A. AL-Nazal , Ali M.A. Al-Kufaishi, Khalid M. Dakhel
Abstract
Atherosclerosis (AS) a is the major underlying clinical mechanism of CVD. Cardiovascular diseases (CVD) are the leading cause of death globally, many factors such as MIF, CX3CL1, GSH and MDA were isociated with atherosclerosis. Materials and method: Sixty back to back patients with conclusion of atherosclerosis along with 30 sound control subjects were enlisted. Venous blood tests were gathered not long before the coronary atheterization methodology (in examination patients). MIF, CX3CL1, GSH and MDA fixation was resolved utilizing financially accessible colorimetric kits
Keywords
Atherosclerosis, MIF, CX3CL1, GSH and MDA.
Copyright
Copyright © Neuroquantology

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.